United States S 1522: A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable.

Status: Introduced in Senate (as of 2023-05-10)

State: United States · Session: 118 · Bill: S 1522

Sponsors: Roger Marshall

View United States S 1522 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.